Financials Universal Biosensors, Inc.
Equities
UBI
AU000000UBI2
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 AUD | 0.00% | 0.00% | -30.00% |
May. 30 | Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call | |
May. 08 | Universal Biosensors Raises AU$10 Million via Entitlement Offer | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 38.95 | 33.74 | 77.26 | 176 | 47.66 | 42.47 |
Enterprise Value (EV) 1 | 27.15 | 3.509 | 57.86 | 163 | 26.52 | 37.2 |
P/E ratio | 1.05 x | -6.33 x | -10.1 x | -16.7 x | -1.67 x | -6.3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.56 x | 4.89 x | 24.1 x | 30.5 x | 10.5 x | 6.4 x |
EV / Revenue | 0.39 x | 0.51 x | 18.1 x | 28.2 x | 5.86 x | 5.61 x |
EV / EBITDA | 0.56 x | -0.39 x | -5.71 x | -13.1 x | -1.26 x | -2.37 x |
EV / FCF | -2.38 x | 0.13 x | -6.93 x | -18.7 x | -2.38 x | -1.87 x |
FCF Yield | -42% | 759% | -14.4% | -5.34% | -42% | -53.4% |
Price to Book | 0.77 x | 0.74 x | 2.03 x | 6.38 x | 1.83 x | 2.18 x |
Nbr of stocks (in thousands) | 177,052 | 177,572 | 177,612 | 177,819 | 211,844 | 212,369 |
Reference price 2 | 0.2200 | 0.1900 | 0.4350 | 0.9900 | 0.2250 | 0.2000 |
Announcement Date | 2/22/19 | 2/26/20 | 2/24/21 | 2/24/22 | 2/24/23 | 2/29/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 69.46 | 6.897 | 3.203 | 5.778 | 4.525 | 6.633 |
EBITDA 1 | 48.54 | -8.89 | -10.13 | -12.47 | -21.09 | -15.71 |
EBIT 1 | 46.42 | -10.4 | -12.56 | -15.04 | -23.88 | -16.68 |
Operating Margin | 66.84% | -150.78% | -392.12% | -260.28% | -527.71% | -251.48% |
Earnings before Tax (EBT) 1 | 41.92 | -6.164 | -7.638 | -10.51 | -29.91 | -6.742 |
Net income 1 | 37.56 | -4.846 | -7.638 | -10.51 | -26.85 | -6.742 |
Net margin | 54.08% | -70.26% | -238.49% | -181.85% | -593.48% | -101.64% |
EPS 2 | 0.2100 | -0.0300 | -0.0430 | -0.0591 | -0.1351 | -0.0317 |
Free Cash Flow 1 | -11.42 | 26.63 | -8.345 | -8.703 | -11.14 | -19.86 |
FCF margin | -16.44% | 386.12% | -260.57% | -150.63% | -246.17% | -299.48% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 2/22/19 | 2/26/20 | 2/24/21 | 2/24/22 | 2/24/23 | 2/29/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 S1 | 2022 S2 |
---|---|---|
Net sales 1 | 3.084 | 1.441 |
EBITDA | - | - |
EBIT 1 | -11.19 | -23.71 |
Operating Margin | -362.75% | -1,644.98% |
Earnings before Tax (EBT) | - | - |
Net income 1 | -9.179 | -17.68 |
Net margin | -297.65% | -1,226.47% |
EPS | - | - |
Dividend per Share | - | - |
Announcement Date | 8/10/22 | 2/24/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 11.8 | 30.2 | 19.4 | 13.1 | 21.1 | 5.27 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -11.4 | 26.6 | -8.35 | -8.7 | -11.1 | -19.9 |
ROE (net income / shareholders' equity) | 118% | -10.1% | -18.3% | -32% | -100% | -29.6% |
ROA (Net income/ Total Assets) | 49.9% | -9.8% | -13.2% | -18.6% | -32.9% | -27.4% |
Assets 1 | 75.25 | 49.45 | 57.92 | 56.39 | 81.55 | 24.61 |
Book Value Per Share 2 | 0.2900 | 0.2600 | 0.2100 | 0.1600 | 0.1200 | 0.0900 |
Cash Flow per Share 2 | 0.0700 | 0.1700 | 0.1300 | 0.0900 | 0.1200 | 0.0500 |
Capex 1 | 0.45 | 10.3 | 0.39 | 0.66 | 1.57 | 1.47 |
Capex / Sales | 0.65% | 149.44% | 12.09% | 11.5% | 34.59% | 22.21% |
Announcement Date | 2/22/19 | 2/26/20 | 2/24/21 | 2/24/22 | 2/24/23 | 2/29/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.00% | 28.88M | |
+7.32% | 217B | |
+13.83% | 194B | |
+20.48% | 143B | |
+31.33% | 111B | |
+3.08% | 64.3B | |
+14.64% | 52.94B | |
+2.72% | 49.53B | |
-5.88% | 38.31B | |
+0.25% | 35.22B |
- Stock Market
- Equities
- UBI Stock
- Financials Universal Biosensors, Inc.